Belmont, MA, United States of America

Kim Tang

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 9.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kim Tang: Innovator in Pharmaceutical Formulations

Introduction

Kim Tang is a prominent inventor based in Belmont, MA (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stimulators for soluble guanylate cyclase (sGC). With a total of five patents to her name, her work is paving the way for new treatments for various diseases.

Latest Patents

Among her latest patents, Kim Tang has focused on sGC stimulators. These stimulators are designed to enhance the concentration of nitric oxide (NO) and cyclic Guanosine Monophosphate (cGMP), which are crucial for treating a range of medical conditions. The patents disclose various compounds, including those of specific formulas, that can be used alone or in combination with other agents to achieve desirable therapeutic effects.

Career Highlights

Throughout her career, Kim has worked with notable companies such as Cyclerion Therapeutics, Inc. and Tisento Therapeutics Inc. Her expertise in pharmaceutical formulations has positioned her as a key player in the industry, contributing to advancements in medical treatments.

Collaborations

Kim has collaborated with esteemed colleagues, including Rajesh R Iyengar and Thomas Wai-Ho Lee. These partnerships have further enriched her research and development efforts in the pharmaceutical field.

Conclusion

Kim Tang's innovative work in the development of sGC stimulators showcases her dedication to advancing medical science. Her contributions are vital for the future of pharmaceutical treatments, and her patents reflect her commitment to improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…